vs
Side-by-side financial comparison of RXO, Inc. (RXO) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
RXO, Inc. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× SELECT MEDICAL HOLDINGS CORP). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs -3.1%, a 4.6% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs -11.9%). SELECT MEDICAL HOLDINGS CORP produced more free cash flow last quarter ($5.2M vs $-9.0M). Over the past eight quarters, RXO, Inc.'s revenue compounded faster (26.8% CAGR vs 2.8%).
RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
RXO vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $1.5B | $1.4B |
| Net Profit | $-46.0M | $20.2M |
| Gross Margin | — | — |
| Operating Margin | -2.9% | 4.6% |
| Net Margin | -3.1% | 1.4% |
| Revenue YoY | -11.9% | 6.4% |
| Net Profit YoY | -84.0% | 225.7% |
| EPS (diluted) | $-0.28 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.4B | $1.4B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.0B | $1.3B | ||
| Q2 24 | $930.0M | $1.3B | ||
| Q1 24 | $913.0M | $1.3B |
| Q4 25 | $-46.0M | $20.2M | ||
| Q3 25 | $-14.0M | $28.8M | ||
| Q2 25 | $-9.0M | $40.6M | ||
| Q1 25 | $-31.0M | $56.7M | ||
| Q4 24 | $-25.0M | $-16.1M | ||
| Q3 24 | $-243.0M | $55.6M | ||
| Q2 24 | $-7.0M | $77.6M | ||
| Q1 24 | $-15.0M | $96.9M |
| Q4 25 | -2.9% | 4.6% | ||
| Q3 25 | -0.5% | 5.4% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | -2.1% | 8.3% | ||
| Q4 24 | -1.4% | 1.6% | ||
| Q3 24 | -1.9% | 4.3% | ||
| Q2 24 | — | 5.8% | ||
| Q1 24 | -1.3% | 9.0% |
| Q4 25 | -3.1% | 1.4% | ||
| Q3 25 | -1.0% | 2.1% | ||
| Q2 25 | -0.6% | 3.0% | ||
| Q1 25 | -2.2% | 4.2% | ||
| Q4 24 | -1.5% | -1.2% | ||
| Q3 24 | -23.4% | 4.4% | ||
| Q2 24 | -0.8% | 6.1% | ||
| Q1 24 | -1.6% | 7.3% |
| Q4 25 | $-0.28 | $0.17 | ||
| Q3 25 | $-0.08 | $0.23 | ||
| Q2 25 | $-0.05 | $0.32 | ||
| Q1 25 | $-0.18 | $0.44 | ||
| Q4 24 | $-0.17 | $-0.12 | ||
| Q3 24 | $-1.81 | $0.43 | ||
| Q2 24 | $-0.06 | $0.60 | ||
| Q1 24 | $-0.13 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $17.0M | $26.5M |
| Total DebtLower is stronger | $387.0M | $1.8B |
| Stockholders' EquityBook value | $1.5B | $1.7B |
| Total Assets | $3.3B | $5.9B |
| Debt / EquityLower = less leverage | 0.25× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.0M | $26.5M | ||
| Q3 25 | $25.0M | $60.1M | ||
| Q2 25 | $18.0M | $52.3M | ||
| Q1 25 | $16.0M | $53.2M | ||
| Q4 24 | $35.0M | $59.7M | ||
| Q3 24 | $55.0M | $191.5M | ||
| Q2 24 | $7.0M | $111.2M | ||
| Q1 24 | $7.0M | $92.6M |
| Q4 25 | $387.0M | $1.8B | ||
| Q3 25 | $387.0M | $1.7B | ||
| Q2 25 | $387.0M | $1.8B | ||
| Q1 25 | $387.0M | $1.8B | ||
| Q4 24 | $351.0M | $1.7B | ||
| Q3 24 | $352.0M | $3.1B | ||
| Q2 24 | $370.0M | $3.6B | ||
| Q1 24 | $351.0M | $3.8B |
| Q4 25 | $1.5B | $1.7B | ||
| Q3 25 | $1.6B | $1.7B | ||
| Q2 25 | $1.6B | $1.7B | ||
| Q1 25 | $1.6B | $1.7B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.7B | $1.9B | ||
| Q2 24 | $579.0M | $1.4B | ||
| Q1 24 | $582.0M | $1.4B |
| Q4 25 | $3.3B | $5.9B | ||
| Q3 25 | $3.2B | $5.7B | ||
| Q2 25 | $3.2B | $5.7B | ||
| Q1 25 | $3.3B | $5.7B | ||
| Q4 24 | $3.4B | $5.6B | ||
| Q3 24 | $3.4B | $8.0B | ||
| Q2 24 | $1.8B | $7.9B | ||
| Q1 24 | $1.8B | $7.9B |
| Q4 25 | 0.25× | 1.06× | ||
| Q3 25 | 0.24× | 1.03× | ||
| Q2 25 | 0.24× | 1.10× | ||
| Q1 25 | 0.24× | 1.03× | ||
| Q4 24 | 0.22× | 1.01× | ||
| Q3 24 | 0.21× | 1.62× | ||
| Q2 24 | 0.64× | 2.54× | ||
| Q1 24 | 0.60× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $7.0M | $64.3M |
| Free Cash FlowOCF − Capex | $-9.0M | $5.2M |
| FCF MarginFCF / Revenue | -0.6% | 0.4% |
| Capex IntensityCapex / Revenue | 1.1% | 4.2% |
| Cash ConversionOCF / Net Profit | — | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.0M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.0M | $64.3M | ||
| Q3 25 | $23.0M | $175.3M | ||
| Q2 25 | $23.0M | $110.3M | ||
| Q1 25 | $-2.0M | $-3.5M | ||
| Q4 24 | $-7.0M | $125.4M | ||
| Q3 24 | $-7.0M | $181.0M | ||
| Q2 24 | $-5.0M | $278.2M | ||
| Q1 24 | $7.0M | $-66.7M |
| Q4 25 | $-9.0M | $5.2M | ||
| Q3 25 | $9.0M | $122.2M | ||
| Q2 25 | $9.0M | $45.6M | ||
| Q1 25 | $-17.0M | $-55.8M | ||
| Q4 24 | $-19.0M | $62.0M | ||
| Q3 24 | $-18.0M | $130.3M | ||
| Q2 24 | $-16.0M | $222.6M | ||
| Q1 24 | $-4.0M | $-119.2M |
| Q4 25 | -0.6% | 0.4% | ||
| Q3 25 | 0.6% | 9.0% | ||
| Q2 25 | 0.6% | 3.4% | ||
| Q1 25 | -1.2% | -4.1% | ||
| Q4 24 | -1.1% | 4.7% | ||
| Q3 24 | -1.7% | 10.2% | ||
| Q2 24 | -1.7% | 17.4% | ||
| Q1 24 | -0.4% | -9.0% |
| Q4 25 | 1.1% | 4.2% | ||
| Q3 25 | 1.0% | 3.9% | ||
| Q2 25 | 1.0% | 4.8% | ||
| Q1 25 | 1.0% | 3.9% | ||
| Q4 24 | 0.7% | 4.8% | ||
| Q3 24 | 1.1% | 4.0% | ||
| Q2 24 | 1.2% | 4.3% | ||
| Q1 24 | 1.2% | 4.0% |
| Q4 25 | — | 3.19× | ||
| Q3 25 | — | 6.09× | ||
| Q2 25 | — | 2.72× | ||
| Q1 25 | — | -0.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 3.59× | ||
| Q1 24 | — | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |